港股異動 | 諾誠健華(09969)現漲超4% BCL2抑制劑ICP-248聯合奧布替尼治療CLL/SLL獲批臨牀 March 14, 2024 by · Published March 14, 2024
0 “木頭姐”迷之投資AI:減持“心頭肉”Unipath(PATH.US),逆市看好Zoom(ZM.US) December 26, 2023 by · Published December 26, 2023